Incidental Findings of Thyroid Detected by PET-CT during Cancer Follow-up

Purpose: The incidence of thyroid cancer is increasing in Korea, partially owing to the development of diagnostic tools. Positron emission tomography (PET)-computed tomography (CT), in particular, has generally been used for evaluation of metastasis and follow-up of malignancy. Methods: We retrospectively investigated 2,833 patients with PET-CT for metastasis work-up or cancer follow-up, which was performed between January 1998 and May 2008 at Inha University Hospital. Of them, abnormal thyroid findings were discovered in 181 patients and we studied the result of further evaluation or follow-up PET-CT. Results: Thyroid cancer was diagnosed in 26 patients, including metastatic cancer in 3 patients, and non-operated primary cancer in 2 patients. Other 21 patients received operation, which in all histopathologically revealed papillary carcinoma. The mean age of the 21 patients was 55.4 years. Nine patients had a history of radiotherapy. The site of malignant nodule was discordant between PET-CT and histopathologic result in 6 patients. The mean size of malignant nodules was 9.45 mm (0.1∼23 mm) with microcarcinoma in 10 patients (47.6%). The mean interval between diagnoses was 15.8 months, and in 4 patients operations for two malignancies were performed in a same day. The incidence of thyroid cancer was significantly high in female patients, but the differences of incidence among different cancer groups were not significant for female patients. Conclusion: Early diagnosis of synchronous or secondary thyroid cancer by PET-CT in cancer patients can make early treatment and better strategies for multiple malignancies possible. (Korean J Endocrine Surg 2010;10:249-255)

[1]  Yong Whi Park,et al.  Characteristics and Detection Rate of Thyroidal Incidentaloma using 18F-FDG PET-CT , 2008 .

[2]  S. Ahn,et al.  Clinical Characteristics of Multiple Primary Cancer in Breast Cancer Patients , 2007 .

[3]  G. Brent,et al.  Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. , 2006, Endocrine-related cancer.

[4]  S. Kohlfuerst,et al.  Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. , 2006, Seminars in nuclear medicine.

[5]  K. Oh,et al.  Sonographic screening for thyroid cancer in females undergoing breast sonography. , 2006, AJR. American journal of roentgenology.

[6]  Kyung-Han Lee,et al.  Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Lubiński,et al.  CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.

[8]  P. Ladenson,et al.  Controversies in the follow-up and management of well-differentiated thyroid cancer. , 2004, Endocrine-related cancer.

[9]  M. Schlumberger,et al.  The risk of multiple primary breast and thyroid carcinomas , 2003, Cancer.

[10]  Seung-Yong Jeong,et al.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[11]  A. Miyauchi,et al.  An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. , 2003, Thyroid : official journal of the American Thyroid Association.

[12]  Jose M. Silva,et al.  Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer , 2002, Oncogene.

[13]  W. Mackillop,et al.  Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma , 2001, Cancer.

[14]  Amy Y. Chen,et al.  The development of breast carcinoma in women with thyroid carcinoma , 2001, Cancer.

[15]  M. Helfand,et al.  Screening high-risk populations for thyroid cancer. , 2001, Medical and pediatric oncology.

[16]  Sarah H. Taylor,et al.  Incidence of breast carcinoma in women with thyroid carcinoma , 1999, Cancer.

[17]  M. Sasaki,et al.  An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. , 1997, Nuclear medicine communications.

[18]  N. Smorodinsky,et al.  Expression of a gene coding for breast tumor-associated antigen in thyroid papillary carcinoma. , 1991, Cancer letters.

[19]  J. Olsen,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. , 1985, National Cancer Institute monograph.

[20]  E. Ron,et al.  Multiple primary breast and thyroid cancer. , 1984, British Journal of Cancer.

[21]  B. Benjamin,et al.  High incidence of breast cancer in thyroid cancer patients. , 1966, British Journal of Cancer.